Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Petz

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
JPEN. Journal of Parenteral and Enteral Nutrition|January 1, 1985
Does long-term home parenteral nutrition in adult patients cause chronic liver disease?B A Bowyer, C R Fleming, J Ludwig, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 26, 2011
The cost of obesity and overweight in 2005: a case study of Alberta, CanadaEllen Moffatt, Lorraine G Shack, Graham J Petz, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|May 1, 1984
Selenium status in patients receiving home parenteral nutritionC R Fleming, J T McCall, J F O'Brien, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 1999
Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosisE J Heathcote, J Stone, K Cauch-Dudek, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitisW R Kim, J J Poterucha, R H Wiesner, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2010
Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acidC Levy, J A Peter, D R Nelson, et al.
Alimentary Pharmacology & Therapeutics|October 1, 2011
High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitisM H Imam, E Sinakos, A A Gossard, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
JPEN. Journal of Parenteral and Enteral Nutrition|January 1, 1985
Does long-term home parenteral nutrition in adult patients cause chronic liver disease?B A Bowyer, C R Fleming, J Ludwig, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 26, 2011
The cost of obesity and overweight in 2005: a case study of Alberta, CanadaEllen Moffatt, Lorraine G Shack, Graham J Petz, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|May 1, 1984
Selenium status in patients receiving home parenteral nutritionC R Fleming, J T McCall, J F O'Brien, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 1999
Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosisE J Heathcote, J Stone, K Cauch-Dudek, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitisW R Kim, J J Poterucha, R H Wiesner, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2010
Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acidC Levy, J A Peter, D R Nelson, et al.
Alimentary Pharmacology & Therapeutics|October 1, 2011
High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitisM H Imam, E Sinakos, A A Gossard, et al.
Pageof 1